This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sciences Sante Et Humaines S.e.c., Bar-Ilan University, Universitéde Montreal. Active years: 2024-2026.
Company Filing History:
2 out of 10 
1 out of 245 
1 out of 189 
Years Active: 2024-2026
Title: Samia Ait-Mohand: Innovator in Synthetic Peptide Mimetics and Gallium-68 Production
Introduction
Samia Ait-Mohand is a notable inventor based in Sherbrooke, Canada. With a focus on synthetic cyclic peptide mimetics and processes for producing gallium-68, Ait-Mohand has made significant contributions to the fields of diagnostics and therapeutic agents.
Latest Patents
Ait-Mohand holds 2 patents. One of the latest patents is titled "Synthetic Cyclic Peptide Mimetics." This patent describes synthetic cyclic peptide mimetics that comprise alternating D-amino acids and L-amino acids, along with amino acid derivatives such as aza-amino acids and azasulfuryl-amino acids. These cyclic peptide mimetics may be conjugated to another agent via a linker, forming cyclic peptide mimetic conjugates. They are intended for use as diagnostic or therapeutic agents for the diagnosis or treatment of amyloidogenic diseases. Another significant patent is related to "Processes and Systems for Producing and/or Purifying Gallium-68." This disclosure outlines processes and systems for producing and purifying gallium-68 from an irradiated substrate of zinc. The process utilizes two cation-exchange chromatography columns to effectively separate gallium from zinc and other radionuclides, achieving a high overall yield and effective molar activity.
Career Highlights
Throughout her career, Ait-Mohand has worked with various organizations, including Société de Commercialisation des Produits de la Recherche Appliquée (Socpra) and Bar-Ilan University. Her work has focused on advancing the production and application of innovative compounds in the medical field.
Collaborations
Ait-Mohand has collaborated with notable colleagues such as Sebastien Tremblay and Brigitte Guerin, who have contributed to her research endeavors.
Conclusion
Samia Ait-Mohand's innovative work in synthetic peptide mimetics and gallium-68 production highlights her significant impact on medical research and diagnostics. Her contributions continue to pave the way for advancements in therapeutic applications.